In vitro and in vivo multidrug resistance reversal activity by a Betti-base derivative of tylosin

被引：0
|
作者：
N Gyémánt
H Engi
Z Schelz
I Szatmári
D Tóth
F Fülöp
J Molnár
P A M de Witte
机构：
[1] Faculty of Medicine,Department of Pharmaceutical Chemistry
[2] Institute of Medical Microbiology and Immunobiology,undefined
[3] University of Szeged,undefined
[4] Faculty of Pharmaceutical Sciences,undefined
[5] Laboratory for Pharmaceutical Biology,undefined
[6] K.U.Leuven,undefined
[7] O&N PB 824,undefined
[8] Faculty of Pharmacy,undefined
[9] University of Szeged,undefined
[10] Zrínyi u.9,undefined
[11] H-6720,undefined
来源：
British Journal of Cancer | 2010年 / 103卷
关键词：
P-glycoprotein; resistance; doxorubicin; tumour; Betti-base; tylosin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：178 / 185
页数：7
相关论文
共 50 条
  • [31] Reversal of multidrug resistance of cancer cells in vitro:: Modification of drug resistance by selected carotenoids
    Gyémant, N
    Tanaka, M
    Molnár, P
    Deli, J
    Mándoky, L
    Molnár, J
    ANTICANCER RESEARCH, 2006, 26 (1A) : 367 - 374
  • [32] Reversal of P-glycoprotein-medicated multidrug resistance by LBM-A5 in vitro and a study of its pharmacokinetics in vivo
    Zhao, Tianxiao
    Song, Yun
    Liu, Baomin
    Qiu, Qianqian
    Jiao, Lei
    Li, Yunman
    Huang, Wenlong
    Qian, Hai
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2015, 93 (01) : 33 - 38
  • [33] In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576
    Mistry, P
    Stewart, AJ
    Dangerfield, W
    Okiji, S
    Liddle, C
    Bootle, D
    Plumb, JA
    Templeton, D
    Charlton, P
    CANCER RESEARCH, 2001, 61 (02) : 749 - 758
  • [34] In vitro and in vivo reversal of MDR1-mediated multidrug resistance by KT-5720: Implications on hematological malignancies
    Galski, Harlan
    Sivan, Hamutal
    Lazarovici, Philip
    Nagler, Arnon
    LEUKEMIA RESEARCH, 2006, 30 (09) : 1151 - 1158
  • [35] In Vivo Evaluation of Eclipta alba Extract as Anticancer and Multidrug Resistance Reversal Agent
    Chaudhary, Harshita
    Jena, Prasant Kumar
    Seshadri, Sriram
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2014, 66 (05): : 904 - 913
  • [36] Jatrophane diterpenoids from Jatropha curcas with multidrug resistance reversal activity
    He, Yi-Lin
    Zhang, Lan-Jun
    Li, Guo-Li
    Yang, Hong-Ying
    Zhang, Lei
    Gong, Zheng
    Gao, Kun
    FITOTERAPIA, 2025, 180
  • [37] Quantitative structure-activity relationship of multidrug resistance reversal agents
    Klopman, G
    Shi, LM
    Ramu, A
    MOLECULAR PHARMACOLOGY, 1997, 52 (02) : 323 - 334
  • [38] Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo
    Wang, L
    Kitaichi, K
    Hui, CS
    Takagi, K
    Takagi, K
    Sakai, M
    Yokogawa, K
    Miyamoto, K
    Hasegawa, T
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (08) : 587 - 593
  • [39] Multidrug resistance activity in human osteosarcoma cell lines and reversal of chemosensitivity
    Gomes, CM
    Van Paassen, HJ
    Welling, MM
    Feitsma, RJ
    Abrunhosa, AJ
    Botelho, MF
    Hogendoorn, PC
    Pauwels, EK
    Cleton-Jansen, AM
    MODERN PATHOLOGY, 2006, 19 : 12A - 12A
  • [40] Multidrug resistance reversal activity of permethyl ningalin B amide derivatives
    Tao, HC
    Hwang, IK
    Boger, DL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (24) : 5979 - 5981
12345